Review the side-effects of Pemigatinib as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.
If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist. •General: Hyperphosphatemia- excess levels of phosphate, tiredness, backpain
•Digestive: Nausea, vomiting, diarrhea, abdominal pain, decreased appetite
•Skin: Nail toxicity, dry skin
•Eye: Dry eyes
•Joints: Joint pain
•Others: Hair fall
•In case of vision problems like blurred vision - refer patients for ophthalmologic evaluation urgently, with follow-up every 3 weeks until resolution of symptom
•The drug may cause dry eyes.
•The drug may increase the levels of phosphate. So phosphate levels to be monitored regularly.
•Female patients with reproductive potential should use effective contraception during treatment and for 1 week after the final dose.
•Males with female partners of reproductive potential should use effective contraception during treatment with PEMAZYRE and for 1 week after the final dose.
If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist. •General: Hyperphosphatemia- excess levels of phosphate, tiredness, backpain
•Digestive: Nausea, vomiting, diarrhea, abdominal pain, decreased appetite
•Skin: Nail toxicity, dry skin
•Eye: Dry eyes
•Joints: Joint pain
•Others: Hair fall
Other Precautions :
•Perform a detailed eye assessment before starting Pemigatinib and every 2 months for the first 6 months and every 3 months thereafter during treatment.•In case of vision problems like blurred vision - refer patients for ophthalmologic evaluation urgently, with follow-up every 3 weeks until resolution of symptom
•The drug may cause dry eyes.
•The drug may increase the levels of phosphate. So phosphate levels to be monitored regularly.
•Female patients with reproductive potential should use effective contraception during treatment and for 1 week after the final dose.
•Males with female partners of reproductive potential should use effective contraception during treatment with PEMAZYRE and for 1 week after the final dose.
